JP2012144537A5 - - Google Patents

Download PDF

Info

Publication number
JP2012144537A5
JP2012144537A5 JP2012040002A JP2012040002A JP2012144537A5 JP 2012144537 A5 JP2012144537 A5 JP 2012144537A5 JP 2012040002 A JP2012040002 A JP 2012040002A JP 2012040002 A JP2012040002 A JP 2012040002A JP 2012144537 A5 JP2012144537 A5 JP 2012144537A5
Authority
JP
Japan
Prior art keywords
formula
pharmaceutically acceptable
compound
compounds
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012040002A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012144537A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2012144537A publication Critical patent/JP2012144537A/ja
Publication of JP2012144537A5 publication Critical patent/JP2012144537A5/ja
Pending legal-status Critical Current

Links

JP2012040002A 2004-09-21 2012-02-27 化合物 Pending JP2012144537A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61129904P 2004-09-21 2004-09-21
US60/611299 2004-09-21

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2004315009A Division JP4976649B2 (ja) 2004-09-21 2004-10-29 化合物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014104217A Division JP5816868B2 (ja) 2004-09-21 2014-05-20 化合物

Publications (2)

Publication Number Publication Date
JP2012144537A JP2012144537A (ja) 2012-08-02
JP2012144537A5 true JP2012144537A5 (hr) 2013-03-28

Family

ID=34956540

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2004315009A Expired - Fee Related JP4976649B2 (ja) 2004-09-21 2004-10-29 化合物
JP2012040002A Pending JP2012144537A (ja) 2004-09-21 2012-02-27 化合物
JP2014104217A Expired - Fee Related JP5816868B2 (ja) 2004-09-21 2014-05-20 化合物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2004315009A Expired - Fee Related JP4976649B2 (ja) 2004-09-21 2004-10-29 化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014104217A Expired - Fee Related JP5816868B2 (ja) 2004-09-21 2014-05-20 化合物

Country Status (2)

Country Link
JP (3) JP4976649B2 (hr)
CN (1) CN101094844B (hr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
CN101056868B (zh) 2004-09-21 2012-05-02 马休爱德华兹股份有限公司 取代的苯并二氢吡喃衍生物、药物及其在治疗中的应用
JP4976649B2 (ja) * 2004-09-21 2012-07-18 マーシャル エドワーズ，インク． 化合物
WO2012061413A2 (en) 2010-11-01 2012-05-10 Marshall Edwards, Inc. Isoflavonoid compositions and methods for the treatment of cancer
CN103224481A (zh) * 2013-05-20 2013-07-31 黑龙江大学 一种去氢雌马酚的制备方法
BR112016018099B8 (pt) * 2014-02-07 2023-01-17 Novogen ltd Compostos funcionalizados de benzopiranos e uso dos mesmos
JP6218680B2 (ja) * 2014-06-11 2017-10-25 三菱電機株式会社 ネットワーク解析支援装置、ネットワーク解析支援方法、および、プログラム
WO2016126618A1 (en) 2015-02-02 2016-08-11 Mei Pharma, Inc. Combination therapies
CN108409701B (zh) * 2017-02-10 2020-09-25 山东康迈祺生物科技有限公司 一种二氢大豆苷元的制备方法
CN112920173A (zh) * 2021-01-25 2021-06-08 江苏师范大学 一种手性苯并二氢吡喃化合物及其合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5883118A (en) * 1996-01-11 1999-03-16 Nova Nordisk A/S Prostatic carcinoma
JP2001502706A (ja) * 1996-10-28 2001-02-27 ノボ ノルディスク アクティーゼルスカブ エストロゲン関連病あるいは症候群の予防または治療に有用な新規トランス―３，４クロマン誘導体
ES2188909T3 (es) * 1996-10-28 2003-07-01 Novo Nordisk As Nuevos derivados de cis-3,4-cromano utiles para la prevencion o tratamiento de sindromes o enfermedades relacionados con el estrogeno. os
KR20000001793A (ko) * 1998-06-13 2000-01-15 이경하 신규한 벤조피란 또는 티오벤조피란 유도체
MXPA03006505A (es) * 2001-01-24 2004-04-21 Chiesi Farma Spa Derivados de 2h-1-benzopirano, procedimiento para su preparacion y sus composiciones farmaceuticas.
JP4976649B2 (ja) * 2004-09-21 2012-07-18 マーシャル エドワーズ，インク． 化合物

Similar Documents

Publication Publication Date Title
JP2012144537A5 (hr)
JP2015537020A5 (hr)
RU2015107803A (ru) Производные дигидроксипиримидинкарбоновой кислоты и их применение в лечении, облегчении или предотвращении вирусного заболевания
WO2012122340A8 (en) Soluble guanylate cyclase activators
JP2020507589A5 (hr)
JP2013522229A5 (hr)
JP2017531038A5 (hr)
CA2637765A1 (en) Benzamide and heteroarene derivatives
EP2581376A4 (en) MATRIC ACID / MATRIN DERIVATIVES AND MANUFACTURING METHOD AND USES THEREOF
JP2017531619A5 (hr)
JP2013545730A5 (hr)
JP2013519645A5 (hr)
MX2018009944A (es) Procedimiento para la preparacion del acido 4-fenil-5-alcoxicarbon il-2-tiazol-2-il-1,4-dihidropirimidin-6-il-[metil]3-oxo-5,6,8,8a- tetrahidro-1h-imidazo[1,5a]pirazin-2-il-carboxilico.
NZ593712A (en) Intermediates for synthesising nucleoside aryl phosphoramidates
JP2013534248A5 (hr)
EP2968372A1 (en) Minocycline derivatives
WO2012018534A3 (en) Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases
JP2012506872A5 (hr)
MX2010007374A (es) Nuevos derivados de c-21-ceto lupano, preparacion y uso de los mismos.
JP2013519653A5 (hr)
JP2011523952A5 (hr)
RU2016122731A (ru) Функционализированные и замещенные индолы в качестве противораковых агентов
BR112014001798A2 (pt) compostos de tetraciclina 9-aminometila substituídos
JP2011505356A5 (hr)
MX2013012588A (es) Inhibidores de cinasa.